PROGgene statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Prognostic biomarker identification TCGA data processing chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases


To access compelling stats and trends, optimize your time and resources and pinpoint new correlations, you will need to subscribe to our premium service.


PROGgene specifications


Unique identifier OMICS_12523
Name PROGgene
Alternative names PROGgeneV2, PROGgeneV1
Interface Web user interface
Restrictions to use Academic or non-commercial use
Computer skills Basic
Version 2.0
Stability Stable
Maintained No


This tool is not available anymore.

Publications for PROGgene

PROGgene in pipeline

PMCID: 5769983
PMID: 29344557
DOI: 10.18632/oncoscience.386

[…] ct method., gene function in human health and disease was assessed using genecards (, survival analysis of human crc adenocarcinoma patients for selected genes was accomplished by proggenev2 [] ( proggene). proggenev2 survival was determined for individual genes or gene signatures from the following cohorts gse41258, gse17537, gse17536. cohorts […]

To access a full list of citations, you will need to upgrade to our premium service.

PROGgene in publications

PMCID: 5847545
PMID: 29531224
DOI: 10.1038/s41467-018-03422-6

[…] cells to taxol (supplementary fig. ). next, we examined whether coasy expression in primary tumors was associated with different clinical outcome in breast cancer cohorts using prognostic database proggene v2. we found that lower level of coasy in primary tumor was associated with poor clinical outcomes in the enerly and steinfeld dataset (gse19783) (supplementary fig. ). the loi dataset […]

PMCID: 5891198
PMID: 29377347
DOI: 10.1111/cas.13518

[…] group had shorter overall survival time than patients in the low expression group (log‐rank, p = .017, figure a) in publicly available gene expression array datasets (tcga) using prognostic database proggene v2. in addition, we found that there was a significant positive correlation between the expression of cd44 and snail in hcc tissue using data sets from tcga and geo (figure b). furthermore, […]

PMCID: 5862617
PMID: 29568396
DOI: 10.18632/oncotarget.24480

[…] and expression of tox2 and irx2 between supratentorial and infratentorial pas, we decided to evaluate the putative prognostic implications of tox2 and irx2 expression using a web-tool called proggenev2 [] on in silico data. patients were classified as high-expression or low-expression groups to generate kaplan-meier plots (figure ) using gene expression data of adult lgg from tcga […]

PMCID: 5799368
PMID: 29402932
DOI: 10.1038/s41467-018-02863-3

[…] gsea (version 2.2.0), was used to analyze the enrichment level of ar-induced genes collected from literature., the kaplan–meier survival analysis was carried out using cbioportal (version 1.4.3),, proggene (version 2), or graphpad prism (version 7.0b). statistical significance of the difference between the survival curves for different groups of patients was assessed using log-rank test., […]

PMCID: 5855628
PMID: 29385725
DOI: 10.3390/ijms19020406

[…] were found in mutation profiles of 290 samples, indicating a high level of sequence conservation., the implication of glo1 overexpression in brain tumors to patients’ outcomes was examined using proggenev2, a web tool for querying prognostic implications of genes in various cancers []. a total of thirteen brain cancer datasets were investigated for overall survival analysis, including gbm (n […]

To access a full list of publications, you will need to upgrade to our premium service.

PROGgene institution(s)
Clinical Genomics, Thomas Jefferson University Hospitals, Philadelphia, PA, USA; Department of Surgery, IU School of Medicine, Indianapolis, IN, USA
PROGgene funding source(s)
Partly supported by IUPUI Breast Cancer Signature Center and Susan G. Komen for the Cure grant SAC110025.

PROGgene reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PROGgene